| Company Name: | ON Assignment, Inc. | | Ticker Symbol: | ASGN | | | WWW Address: | www.onassignment.com | | CEO: | Peter T. Dameris | | No. of Employees: | 1,134 | | Common Issue Type: | CS | | Business Description: | A professional staffing firm, which provides flexible and permanent staffing solutions in specialty skills including Laboratory/Scientific, Healthcare/Nursing, Physicians, Medical Financial, Information Technology and Engineering.
|
| | | Industry Information: | DIVERSIFIED SERVICES - Staffing & Outsourcing Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 6.33 |  0.0 | 5.73 | 6.89 | 6.34 | 6.40 | 6.24 | 112958 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 228.5 | 36.1 | 2.00 | 0.53 | 0.00 | 30.1 | 0.0 | 6.80 - 1.28 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 6.33 | $ | | PE Ratio - LTM | 30.1 | |
| Market Capitalisation | 228.5 | mil |
| Latest Shares Outstanding | 36.1 | mil |
| Earnings pS (EPS) | 0.53 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 545,025 | $ |
| Effective Tax Rate | 44.6 | % |
| Float | 35.2 | mil |
| Float as % of Shares Outstanding | 97.1 | % |
| Foreign Sales | 34 | mil |
| Domestic Sales | 584 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 28.00 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 35.4 | % |
| EBITDA Margin | 7.5 | % |
| Pre-Tax Profit Margin | 3.1 | % |
| Assets Turnover | 1.2 | % |
| Return on Assets (ROA) | 2.1 | % |
| Return on Equity (ROE) | 3.2 | % |
| Return on Capital Invested (ROCI) | 2.3 | % |
| Current Ratio | 2.5 | |
| Leverage Ratio (Assets/Equity) | 1.6 | |
| Interest Cover | 2.9 | |
| Total Debt/Equity (Gearing Ratio) | 0.37 | |
| LT Debt/Total Capital | 27.0 | % |
| Working Capital pS | 1.66 | $ |
| Cash pS | 0.97 | $ |
| Book-Value pS | 6.25 | $ |
| Tangible Book-Value pS | -0.11 | $ |
| Cash Flow pS | 0.55 | $ |
| Free Cash Flow pS | 1.09 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.01 | |
| Price/Tangible Book Ratio | -56.01 | |
| Price/Cash Flow | 11.4 | |
| Price/Free Cash Flow | 5.8 | |
| P/E as % of Industry Group | 66.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 1.4 | 100 | 1,268 | 3,703 |
| 4 Weeks | 6.80 | 5.72 | 6.04 | 4.8 | 98 | 1,454 | 26,175 |
| 13 Weeks | 6.80 | 3.74 | 4.29 | 47.6 | 137 | 1,796 | 111,328 |
| 26 Weeks | 6.80 | 3.49 | 3.57 | 77.3 | 147 | 1,571 | 197,923 |
| 52 Weeks | 6.80 | 1.28 | 5.75 | 10.1 | 89 | 1,890 | 472,588 |
| YTD | 6.80 | 1.28 | - | 11.6 | 91 | 1,758 | 400,804 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 6.28 | 6.28 | 6.11 | 4.72 | 4.22 | 2.00 | 1.86 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 25.99 | 79.7 | 20.17 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 63.20 | NA | 133.32 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -32.7 | -39.5 | 9.0 |
| Earnings % | -76.2 | -79.0 | 103.5 |
| EPS % | -76.7 | -78.9 | 103.8 |
| EPS $ | -0.33 | -0.15 | 0.27 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 22.69 |
| Current Ratio | 2.7 |
| Quick Ratio (Acid Test) | 2.3 |
| Liquidity Ratio (Cash) | 0.86 |
| Receivables Turnover | 7.9 |
| Average Collection Period | 46 |
| Working Capital/Equity | 41.7 |
| Working Capital pS | 2.55 |
| Cash-Flow pS | 0.94 |
| Free Cash-Flow pS | 0.51 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 2.95 |
| Financial Leverage Ratio (Assets/Equity) | 1.8 |
| Debt Ratio | 45.6 |
| Total Debt/Equity (Gearing Ratio) | 0.58 |
| LT Debt/Equity | 0.58 |
| LT Debt/Capital Invested | 37.7 |
| LT Debt/Total Liabilities | 68.7 |
| Interest Cover | 4.4 |
| Interest/Capital Invested | 2.87 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 3.65 |
| Tobin's Q Ratio | 0.57 |
| Current P/E Ratio - LTM | 30.10 |
| Enterprise Value (EV)/EBITDA | 6.30 |
| Enterprise Value (EV)/Free Cash Flow | 44.11 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -56.01 |
| Price/Book Ratio - LTM | 1.01 |
| Price/Cash Flow Ratio | 11.4 |
| Price/Free Cash Flow Ratio - LTM | 5.8 |
| Price/Sales Ratio | 0.49 |
| P/E Ratio (1 month ago) - LTM | 25.2 |
| P/E Ratio (26 weeks ago) - LTM | 7.0 |
| P/E Ratio (52 weeks ago) - LTM | 11.7 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 66.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 30.1 |
| PER SHARE FIGURES |
| LT Debt pS | 3.53 |
| Current Liabilities pS | 1.50 |
| Tangible Book Value pS - LTM | -0.11 |
| Book Value pS - LTM | 6.25 |
| Capital Invested pS | 9.54 |
| Cash pS - LTM | 0.97 |
| Cash Flow pS - LTM | 0.55 |
| Free Cash Flow pS - LTM | 1.09 |
| Earnings pS (EPS) | 0.53 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 2.94 |
| Free Cash Flow Margin 5YEAR AVG | -7.33 |
| Net Profit Margin | 3.1 |
| Net Profit Margin - 5YEAR AVRG. | -0.2 |
| Equity Productivity | 2.83 |
| Return on Equity (ROE) | 8.7 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 1.79 |
| Return on Capital Invested (ROCI) | 5.5 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -0.3 |
| Assets Productivity | 1.60 |
| Return on Assets (ROA) | 4.7 |
| Return on Assets (ROA) - 5YEAR AVRG. | -0.3 |
| Gross Profit Margin | 35.4 |
| Gross Profit Margin - 5YEAR AVRG. | 32.8 |
| EBITDA Margin - LTM | 7.5 |
| EBIT Margin - LTM | 4.7 |
| Pre-Tax Profit Margin | 5.5 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 0.8 |
| Effective Tax Rate | 44.6 |
| Effective Tax Rate - 5YEAR AVRG. | 32.1 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 46 |
| Revenue per Employee | 545,025 |
| Net Income per Employee | 16,728 |
| Average Collection Period | 46 |
| Receivables Turnover | 7.9 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 0.84 |
| Assets/Revenue | 0.63 |
| Net Working Capital Turnover | 6.78 |
| Fixed Assets Turnover | 2.40 |
| Total Assets Turnover | 1.6 |
| Revenue per $ Cash | 13.36 |
| Revenue per $ Plant | 35.33 |
| Revenue per $ Common Equity | 2.83 |
| Revenue per $ Capital Invested | 1.79 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 25.2 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 26.6 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |